One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.

C K SvenssonJ R LarsenL VedtofteM S L JakobsenH R JespersenMichelle Iris JakobsenK KoyuncuO SchjerningJ NielsenC T EkstrømChristoph U CorrellT VilsbøllA Fink-Jensen

Published in: Acta psychiatrica Scandinavica (2018)

The body weight reduction during 16 weeks of liraglutide treatment was partially sustained 1 year after the intervention was completed. However, the improvements in other metabolic parameters returned to baseline levels.

Keyphrases

body weight
end stage renal disease
newly diagnosed
weight loss
randomized controlled trial
ejection fraction
chronic kidney disease
weight gain
physical activity
prognostic factors
body mass index
adipose tissue
skeletal muscle
smoking cessation
preterm birth